vimarsana.com

Page 14 - ப்ளூம்பெர்க் தடுப்பூசி டிராக்கர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The end of US mass vaccination is coming sooner rather than later

Almost all of those who get a first dose are likely to get their second, according to one CDC study. On top of that, more than 80% of people age 60 or over the most vulnerable group have had a dose and will likewise complete vaccination.

Vaccination campaign ready for new phase

FAIRFIELD-SUISUN, CALIFORNIA Hundreds line up to get Covid-19 vaccine shots at Dodger Stadium in Los Angeles, Feb. 8. (Robert Gauthier/Los Angeles Times/TNS file photo) Vaccination campaign ready for new phase After three months of vaccination across the U.S., a majority of American adults have gotten shots, and the effort will soon shift from mass inoculation to mop-up. As of Saturday, 138.6 million people in the U.S. have received at least one Covid-19 vaccine shot. About 1.3 million more are getting a first dose every day, according to the Centers for Disease Control and Prevention. While the rate of new vaccinators is declining, even if were immediately cut in half, it would mean that six weeks from now more than half of the population of the U.S. and its territories will have had a dose.

J&J s second act creates new challenge for immunization effort

J&J s second act creates new challenge for immunization effort
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

International response to India s huge Kovid crisis

International response to India s huge Kovid crisis
naveenbharat.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naveenbharat.in Daily Mail and Mail on Sunday newspapers.

J&J s second act creates new challenge for immunization effort | Nation/World

For Americans wary of the Johnson & Johnson COVID-19 vaccine as it returns to use after the investigation of a potentially deadly side effect, health experts have a message: The system worked. A recommended hold on the vaccine was lifted on Friday by the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration after a 10-day review of rare and serious blood clots in some people who had received the shot. The small risk of clots from the shot is far outweighed by its protection against the coronavirus, an advisory panel said. In the next six months, the shot could prevent some 1,435 COVID-19 deaths and 2,236 hospitalizations, compared with a projected 26 possible clot cases, according to a presentation by the CDC.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.